1. N. Collongues, R. Marignier, H. Zephir, C. Papeix, F. Blanc, C. Ritleng, M. Tchikviladze, O. Outteryck, S. Vukusic, M. Fleury, B. Fontaine, D. Brassat, M. Clanet, M. Milh, J. Pelletier, B. Audoin, A. Ruet, C. Lebrun-Frenay, E. Thouvenot, W. Camu, M. Debouverie, A. Creange, T. Moreau, P. Labauge, G. Castelnovo, G. Edan, E. Le Page, G. Defer, B. Barroso, O. Heinzlef, O. Gout, D. Rodriguez, S. Wiertlewski, D. Laplaud, F. Borgel, P. Tourniaire, J. Grimaud, B. Brochet, P. Vermersch, C. Confavreux, and J. de Seze. Neuromyelitis optica in France: A multicenter study of 125 patients. Neurology, 74(9):736-42, 2010. Note: Journal ArticleUnited States. [WWW]



2. C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun-Frenay, J. Pelletier, T. Moreau, C. Lubetzki, P. Vermersch, E. Roullet, L. Magy, M. Tardieu, S. Suissa, and C. Confavreux. Natural history of multiple sclerosis with childhood onset. N Engl J Med, 356(25):2603-13, 2007. Note: Adult Neurology Departments KIDMUS Study GroupComparative StudyJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, *Age of Onset, Child, Child, Preschool, Cohort Studies, Disease Progression, Female, Humans, Infant, Kaplan-Meiers Estimate, Male, *Multiple Sclerosis, Observation, Prognosis.



3. E. Le Page, E. Leray, B. Brochet, M. Clanet, P. Clavelou, C. Confavreux, M. Debouverie, C. Lebrun, C. Lubetzki, M. Madigand, J. Pelletier, E. Roullet, L. Rumbach, D. Brassat, and G. Edan. Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: final report. Mult Scler, 12:S211-S211, 2006. Note: Suppl. 1. [WWW]



4. C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun-Frenay, J. Pelletier, T. Moreau, C. Lubetzki, P. Vermersch, E. Roullet, L. Magy, M. Tardieu, S. Suissa, and C. Confavreux. Childhood onset multiple sclerosis (the KIDMUS study): course and prognosis as compared to adult onset multiple sclerosis. Mult Scler, 12:S130-S131, 2006. Note: Suppl. 1. [WWW]



5. B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, L. Rumbach, T. Moreau, J. Pelletier, C. Lubetzki, and M. Clanet. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology, 64(7):1139-43, 2005. Note: French Modafinil Study GroupJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Benzhydryl Compounds/*administration & dosage/adverse effects, Central Nervous System Stimulants/*administration & dosage/adverse effects, Double-Blind Method, Fatigue/*drug therapy/etiology/prevention & control, Female, Gastrointestinal Diseases/chemically induced, Humans, Male, Middle Aged, Multiple Sclerosis/*complications, Placebos, Sleep Initiation and Maintenance Disorders/chemically induced, Treatment Outcome.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html